In vivo purging and relapse prevention following ASCT

This publication has 22 references indexed in Scilit:

• Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
  Blood, 2001
• A quantitative study of peripheral blood stem cell contamination in diffuse large‐cell non‐Hodgkin's lymphoma: one‐half of patients significantly mobilize malignant cells
  British Journal of Haematology, 2000
• In vivodepletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma
  British Journal of Haematology, 2000
• Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
  Blood, 1999
• Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)
  Bone Marrow Transplantation, 1999
• Should we purge?
  Bone Marrow Transplantation, 1998
• Purging Peripheral Blood Progenitor Cell Grafts from Lymphoma Cells: Quantitative Comparison of Immunomagnetic CD34 ⁺ Selection Systems
  The International Journal of Cell Cloning, 1997
• Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs
  Cancer Biotherapy & Radiopharmaceuticals, 1997
• Comparative Preclinical Study of Three Bone Marrow Purging Methods Using PCR Evaluation of Residual t(14;18) Lymphoma Cells
  Leukemia & Lymphoma, 1996
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995